Table 1 SLAB51 effect on locomotor activities.

From: Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels

Weeks 8 12 18 24
Ambulatory counts
AD control 571 ± 52.82 340 ± 55.16 384 ± 10.48 297 ± 8.53
AD + SLAB51 556 ± 80.92 367 ± 49.19 351 ± 14.55 298 ± 15.31
Stereotypic counts
AD control 416 ± 12.60 378 ± 18.69 350 ± 13.60 313 ± 20.58
AD + SLAB51 410 ± 13.93 343 ± 21.83 325 ± 20.67 302 ± 19.47